Abstract
We have studied prototypes of platelet substitutes and focused on the dodecapeptide (H12); a part of the amino acid sequence of fibrinogen as activated platelets, and conjugated H12 to the surface of polymerized albumin particles (polyAlb) as biocompatible and biodegradable particles. The H12-conjugated polyAlb (H12-polyAlb) adding to the thrombocytopenic-imitation blood enhanced the platelet thrombus formation on a collagen-plate in vitro. We confirmed that H12-polyAlb had a hemostatic effect, based on the analysis of the tail bleeding time of thrombocytopenic rats. H12-polyAlb is a suitable candidate for an alternative to human platelet concentrates infused into thrombocytopenic patients.
Original language | English |
---|---|
Pages | 4933-4934 |
Number of pages | 2 |
Publication status | Published - 2005 Dec 1 |
Event | 54th SPSJ Symposium on Macromolecules - Yamagata, Japan Duration: 2005 Sept 20 → 2005 Sept 22 |
Other
Other | 54th SPSJ Symposium on Macromolecules |
---|---|
Country/Territory | Japan |
City | Yamagata |
Period | 05/9/20 → 05/9/22 |
Keywords
- Fibrinogen γ chain dodecapeptide (H12)
- Flow conditions
- Haemostatic effects
- Platelet substitutes
- Polymerized albumin particles (polyAlb)
- Thrombocytopenic rats
ASJC Scopus subject areas
- Engineering(all)